AcouSort AB (SE:ACOU)

:ACOU

ACOU

AcouSort AB

RESEARCH TOOLSreports

Want to see SE:ACOU full AI Analyst Report?

AcouSort AB (ACOU) Price & Analysis

0 Followers

ACOU Stock Chart & Stats

kr2.64

-kr3.18(-45.56%)

At close: Mar 06 4:00 PM EST

kr2.64

-kr3.18(-45.56%)

Day’s Range― - ―

52-Week Rangekr2.03 - kr5.00

Previous CloseN/A

Volume449.84K

Average Volume (3M)29.24K

Market Cap

kr102.01M

Enterprise Valuekr95.72M

Total Cash (Recent Filing)kr6.29M

Total Debt (Recent Filing)kr0.00

Price to Earnings (P/E)―

Beta0.20

Next Earnings

May 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.65

Shares Outstanding21,163,902

10 Day Avg. Volume27,764

30 Day Avg. Volume29,240

Financial Highlights & Ratios

PEG Ratio0.12

Price to Book (P/B)3.27

Price to Sales (P/S)7.79

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.3

Revenue Forecast (FY)kr10.70M

Bulls Say, Bears Say

Bulls Say

Debt-free Balance SheetZero reported debt materially reduces refinancing and interest-rate risk, giving management durable financial optionality. Over a 2–6 month horizon this structural strength supports continued R&D and partnership efforts without immediate refinancing pressure, improving strategic flexibility.

Recovering Revenue GrowthA 22% revenue recovery in 2025 signals improving product demand and early commercial traction for acoustofluidic modules. Sustained top-line growth, if continued, supports scaling fixed R&D and manufacturing costs, increasing the odds of moving toward positive operating leverage over the medium term.

Niche, High‑value End MarketsThe company targets cell therapy manufacturing and diagnostics—structural, high-growth markets with specialized needs. Its acoustofluidic module approach can create sticky OEM integrations and technical differentiation, supporting sustainable competitive advantage if adoption continues.

Bears Say

Persistent UnprofitabilityConsistent multi-year net losses and deeply negative EBIT/EBITDA indicate the business has not yet reached profitable unit economics. This structural unprofitability risks continued margin erosion and limits retained-earnings buildup, constraining the company’s ability to self-finance growth over time.

Weak Cash GenerationNegative operating and free cash flow in recent years show the core business is not self-funding. Over the medium term this elevates funding and execution risk, may force management to prioritize short-term liquidity over strategic investments, and increases vulnerability to market funding shocks.

Reliance On Equity FundingVolatile equity levels imply recurring capital raises to cover cash burn. Persistent reliance on external equity dilutes shareholders and can limit strategic options if capital access tightens, making long-term planning and investor returns dependent on continued market financing.

ACOU FAQ

What was AcouSort AB’s price range in the past 12 months?

AcouSort AB lowest stock price was kr2.03 and its highest was kr5.00 in the past 12 months.

What is AcouSort AB’s market cap?

AcouSort AB’s market cap is kr102.01M.

When is AcouSort AB’s upcoming earnings report date?

AcouSort AB’s upcoming earnings report date is May 27, 2026 which is in 3 days.

How were AcouSort AB’s earnings last quarter?

AcouSort AB released its earnings results on Feb 25, 2026. The company reported -kr0.139 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.139.

Is AcouSort AB overvalued?

According to Wall Street analysts AcouSort AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does AcouSort AB pay dividends?

AcouSort AB does not currently pay dividends.

What is AcouSort AB’s EPS estimate?

AcouSort AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does AcouSort AB have?

AcouSort AB has 21,163,902 shares outstanding.

What happened to AcouSort AB’s price movement after its last earnings report?

AcouSort AB reported an EPS of -kr0.139 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.775%.

Which hedge fund is a major shareholder of AcouSort AB?

Currently, no hedge funds are holding shares in SE:ACOU

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

AcouSort AB

AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company was founded in 2010 and is based in Lund, Sweden.